LIAISON XL QuantiFERON-TB
Device
DiaSorin Inc.
Total Payments
$56,527
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $56,527 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $56,527 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| LIAISON XL QuantiFERON-TB Gold Plus Assay, Project 500461 | DiaSorin Inc. | $56,527 | 0 |
Top Doctors Receiving Payments for LIAISON XL QuantiFERON-TB
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Minneapolis, MN | $56,527 | 2 |
Ad
Manufacturing Companies
- DiaSorin Inc. $56,527
Product Information
- Type Device
- Total Payments $56,527
- Total Doctors 0
- Transactions 2
About LIAISON XL QuantiFERON-TB
LIAISON XL QuantiFERON-TB is a device associated with $56,527 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is DiaSorin Inc..
Payment data is available from 2018 to 2018. In 2018, $56,527 was paid across 2 transactions to 0 doctors.
The most common payment nature for LIAISON XL QuantiFERON-TB is "Unspecified" ($56,527, 100.0% of total).
LIAISON XL QuantiFERON-TB is associated with 1 research study, including "LIAISON XL QuantiFERON-TB Gold Plus Assay, Project 500461" ($56,527).